Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
The New England Journal of Medicine
|
October 16, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
Nicholas van As, Clare Griffin, Alison Tree, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
September 28, 2024
Satisfaction in surgically treated patients with degenerative cervical myelopathy: an observational study from the Canadian Spine Outcomes and Research Network
William Chu Kwan, Tamir Ailon, Nicolas Dea, et al.
The Lancet. Oncology
|
September 22, 2019
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H Brand, Alison C Tree, Peter Ostler, et al.
Journal of Neurosurgery. Spine
|
January 30, 2026
Cervical spine chordomas: surgical outcome assessment in a multicenter cohort from the Primary Tumor Research and Outcomes Network
Julien F Zaldivar-Jolissaint, William Chu Kwan, Charles G Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2025
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney
Muhammad Ali, Rohann J M Correa, David Pryor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 15, 2023
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Aly-Khan A Lalani, Anil Kapoor, Naveen S Basappa, et al.
Global Spine Journal
|
January 13, 2025
What is the Optimal Management of Metastatic Spine Patients With Intermediate Spinal Instability Neoplastic Scores: To Operate or Not to Operate?
William Chu Kwan, Scott L Zuckerman, Charles G Fisher, et al.
The Lancet. Oncology
|
September 16, 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Alison C Tree, Peter Ostler, Hans van der Voet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 19, 2022
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
Samantha C Sodergren, Colin D Johnson, Alexandra Gilbert, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
The New England Journal of Medicine
|
October 16, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
Nicholas van As, Clare Griffin, Alison Tree, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
September 28, 2024
Satisfaction in surgically treated patients with degenerative cervical myelopathy: an observational study from the Canadian Spine Outcomes and Research Network
William Chu Kwan, Tamir Ailon, Nicolas Dea, et al.
The Lancet. Oncology
|
September 22, 2019
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H Brand, Alison C Tree, Peter Ostler, et al.
Journal of Neurosurgery. Spine
|
January 30, 2026
Cervical spine chordomas: surgical outcome assessment in a multicenter cohort from the Primary Tumor Research and Outcomes Network
Julien F Zaldivar-Jolissaint, William Chu Kwan, Charles G Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2025
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney
Muhammad Ali, Rohann J M Correa, David Pryor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 15, 2023
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Aly-Khan A Lalani, Anil Kapoor, Naveen S Basappa, et al.
Global Spine Journal
|
January 13, 2025
What is the Optimal Management of Metastatic Spine Patients With Intermediate Spinal Instability Neoplastic Scores: To Operate or Not to Operate?
William Chu Kwan, Scott L Zuckerman, Charles G Fisher, et al.
The Lancet. Oncology
|
September 16, 2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Alison C Tree, Peter Ostler, Hans van der Voet, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 19, 2022
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
Samantha C Sodergren, Colin D Johnson, Alexandra Gilbert, et al.
Page
of 13